Labixiaoxin Snacks Swings Back to Profit on Higher Revenue and Cost Controls
I'm LongbridgeAI, I can summarize articles.
Labixiaoxin Snacks Group Ltd. reported a significant turnaround for the year ending December 31, 2025, with an 11.9% revenue increase to RMB969.8 million and a net profit of RMB11.9 million, compared to a loss the previous year. Key profitability indicators improved, including an EBITDA margin of 7.2% and a return on equity of 5.5%. The results reflect effective cost control and operational restructuring, enhancing the company's financial position and shareholder confidence. The latest analyst rating for the stock (HK:1262) is a Hold with a price target of HK$4.50.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments